Charles River Labs Intl sell Citigroup Inc.
Start price
01.10.24
/
50%
€175.45
Target price
01.10.25
€158.03
Performance (%)
-14.05%
Price
17:49
€150.80
Summary
This prediction is currently active. The price of Charles River Labs Intl has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.05%. This prediction currently runs until 01.10.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | 8.272% | 8.272% |
| iShares Core DAX® | -1.184% | 0.861% |
| iShares Nasdaq 100 | 3.941% | 6.184% |
| iShares Nikkei 225® | -1.206% | -0.294% |
| iShares S&P 500 | 3.141% | 5.930% |
Comments by Citigroup_Inc_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $175.00 price target on the stock, down previously from $215.00.
Ratings data for CRL provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€135.75
09.07.25
09.07.25
€170.62
09.07.26
09.07.26
11.09%
17:49
17:49
